Seeing Is Believing
Healthcare - Sector
UTHR is currently covered by 11 analysts with an average price target of $608. This is a potential upside of $74.02 (19.57%) from yesterday's end of day stock price of $508.48.
United Therapeutics's activity chart (see below) currently has 226 price targets and 165 ratings on display. The stock rating distribution of UTHR is 70.27% BUY and 29.73% HOLD.
Analysts average stock forecasts to be materialized ratio is 86.08% with an average time for these price targets to be met of 257.32 days.
Highest price target for UTHR is $738, Lowest price target is $414, average price target is $608.
Most recent stock forecast was given by LISA WALTER from RBC on 06-Aug-2026.
Currently out of the existing stock ratings of UTHR, 26 are a BUY (70.27%), 11 are a HOLD (29.73%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Sep-2025
$677
$177.27 (35.47%)
$704
Buy Since 14-Sep-2020
$687
$187.27 (37.47%)
$450
Hold Since 01-May-2025
$613
$113.27 (22.67%)
$626
Hold Since 30-Oct-2025
$738
$195.34 (36.00%)
$575
Hold Since 11-Oct-2024
$519
$-23.66 (-4.36%)
$435
What is UTHR (United Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on UTHR (United Therapeutics) with a proven track record?
Which analyst has the most public recommendations on UTHR (United Therapeutics)?
Which analyst is the currently most bullish on UTHR (United Therapeutics)?
Which analyst is the currently most reserved on UTHR (United Therapeutics)?